A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer

You may be eligible if

• Females diagnosed with breast cancer and the cancer has spread to distant areas of the breast or organs.
• Must be able to measure the disease by specific medical parameters
• May have received breast cancer treatment in the early stage of the disease
• May be restricted in physically strenuous activity but able to carry out light work.
• Must have adequate organ function as seen in blood test results.
• Exclusion
• Criteria:
• Cancer that has spread to the brain.
• Unstable heart problems
• Unstable high blood pressure.
• Breast cancer treatment after the disease has considered to spread to other areas or organs.
• Unable to agree with the requirements of the study